Tag: hypervascular tumour
Instylla first-in-human clinical trial published results demonstrate success
A prospective multicentre study has evaluated the safety and efficacy of a polyethylene glycol (PEG)-based liquid embolic in treating hypervascular tumours, according to an...
Scitech Medical’s Embosoft microspheres receive CE mark approval for vascular embolization
Scitech Medical, has announced that it has received CE mark approval for the Embosoft microspheres for use in vascular embolization of hypervascular tumours, symptomatic...
First patients enrolled in the Embrace hydrogel embolic system global randomised...
The initial patients have been enrolled in the Embrace hydrogel embolic system (HES) global randomised clinical trial for the treatment of hypervascular tumours, Instylla...
ABK Biomedical appoints Michael J Mangano as president and CEO
ABK Biomedical, a company dedicated to the research, development and commercialisation of innovative embolic therapies, has announced the appointment of Michael J Mangano as...
